Kiltearn Partners’s Cigna CI Stock Holding History

Kiltearn Partners’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.9M	Sell	74,613 -15,800	-17%	-$4.37M	5.36%	7
2025 Q4	$24.9M	Sell	90,413 -7,387	-8%	-$2.07M	5.39%	6
2025 Q3	$28.2M	Buy	97,800 +7,900	+9%	+$2.34M	5.65%	5
2025 Q2	$29.7M	Sell	89,900 -5,000	-5%	-$1.61M	5.98%	5
2025 Q1	$31.2M	Sell	94,900 -6,400	-6%	-$1.93M	5.95%	6
2024 Q4	$28M	Sell	101,300 -1,100	-1%	-$351K	4.62%	7
2024 Q3	$35.5M	Sell	102,400 -20,600	-17%	-$7.09M	4.82%	6
2024 Q2	$40.7M	Sell	123,000 -28,300	-19%	-$9.76M	4.93%	6
2024 Q1	$55.1M	Sell	151,300 -14,200	-9%	-$4.67M	5.09%	5
2023 Q4	$49.6M	Buy	165,500 +2,900	+2%	+$847K	3.81%	9
2023 Q3	$46.5M	Sell	162,600 -10,900	-6%	-$3.11M	3.67%	8
2023 Q2	$48.7M	Buy	173,500 +61,400	+55%	+$16M	3.56%	9
2023 Q1	$28.6M	Sell	112,100 -500	-0.4%	-$146K	2.07%	22
2022 Q4	$37.3M	Sell	112,600 -43,100	-28%	-$13.6M	2.74%	16
2022 Q3	$43.2M	Sell	155,700 -16,000	-9%	-$4.5M	2.5%	20
2022 Q2	$45.2M	Buy	171,700 +79,500	+86%	+$20.5M	2.37%	24
2022 Q1	$22.1M	Buy	+92,200	New	+$21.6M	0.95%	34

Other funds holding CI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Kiltearn Partners's CI Position: Q1 2026 in Review

Kiltearn Partners reduced its Cigna (CI) stake by 17% in Q1 2026, selling an estimated $4.37M and leaving 74,613 shares worth $19.9M. The position accounts for 5.36% of the portfolio, ranked #7.

Kiltearn Partners first reported a position in CI in Q1 2022 and has held it in 17 quarters since. The position peaked at $55.1M in Q1 2024. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

Kiltearn Partners held 74,613 shares of Cigna worth $19.9M as of Q1 2026.
Kiltearn Partners sold 15,800 Cigna shares in Q1 2026, an estimated $4.37M.
Cigna made up 5.36% of Kiltearn Partners's portfolio in Q1 2026, its #7 holding.
Kiltearn Partners first reported a position in Cigna in Q1 2022 and has held it in 17 quarters since.
Kiltearn Partners's Cigna position peaked at $55.1M in Q1 2024.
1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Kiltearn Partners's 13F filing for Q1 2026, filed 14 May 2026.